Index of /docs/cpg

• Parent Directory
• 1.0envspn_07_FINAL.pdf
• 10.1Dose PN_FINAL.pdf
• 10.2_uselipids_FINAL.pdf
• 10.3mode_FINAL.pdf
• 10.4 insulin_May 2009.pdf
• 11.1_anti_comb_FINAL.pdf
• 11.2_selenium_FINAL.pdf
• 2.0early_FINAL.pdf
• 3.1use of indirect_FINAL.pdf
• 3.2target_FINAL.pdf
• 4.1a_arginine_FINAL.pdf
• 4.1bfish oils_FINAL.pdf
• 4.1c_englu_FINAL.pdf
• 4.1dOKG_FINAL.pdf
• 4.2ahighfat_FINAL.pdf
• 4.2bLow fat_FINAL.pdf
• 4.2cHighprotein_FINAL.pdf
• 4.3peptide_FINAL.pdf
• 4.4pH_FINAL.pdf
• 4.5fibre_FINAL.pdf
• 5.1protocols_FINAL.pdf
• 5.2Motility_FINAL.pdf
• 5.3Smallbowel_FINAL.pdf
• 5.4Bodyposition_FINAL.pdf
• 6.1Closed_FINAL.pdf
• 6.2Probiotics_May 2009.pdf
• 6.3continuous_FINAL.pdf
• 6.4PEGvsNG_FINAL.pdf
• 7en+pn_FINAL.pdf
• 8PNvsStd_FINAL.pdf
• 9.1_ bcaa_FINAL.pdf
• 9.2lipidtype_May 2009.pdf
• 9.3zinc_FINAL_May 2009.pdf
• 9.4pnglu_FINAL.pdf
• CPG Changes 2009.pdf
• CPG Summary 2009.pdf
• protocolrev.pdf
• protocolrev_old.pdf
• srrev.pdf